Venous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding...
Keywords: Venöse Thrombose, Rezidiv, sekundäre Thromboseprophylaxe, Vitamin-K-Antagonisten, Risikofaktoren
01/2006 | Hämostaseologie, Schattauer